The Quantellect read.As of Nov 19, 2026, 6 active firms cover Bowhead Specialty Holdings Inc: 2 rate it Buy or better, 4 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $33.00 to $36.00, so the covering firms are broadly aligned. The average target of $34.67 sits 1% above the current $34.32. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.56 next quarter toward $2.46 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Neutral
Strong Buy00%
Buy233%
Neutral467%
Sell00%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$34.67
+1.0% upside
Average target across 6 active firms as of Nov 19, 2026 vs $34.32 current
Highest Target$36.00
Average Target$34.67
Lowest Target$33.00
Detailed analyst forecasts for BOW
Showing 1–7 of 7 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 2 of 6 active firms rate BOW a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BOW EPS & revenue forecast
EPS · NEXT QUARTER
$0.56
Range $0.53 – $0.59 · 5 analysts · +17% YoY
Next period, 5 analysts expect Bowhead Specialty Holdings Inc. to earn $0.56 a share (range $0.53 – $0.59), versus $0.48 a year earlier. Full-year consensus is $2.03, growing to $2.46 the year after.
REVENUE · NEXT QUARTER
$186.0M
Range $182.8M – $189.9M · 5 analysts · +19% YoY
Revenue is expected to reach $186.0M (range $182.8M – $189.9M), +19.5% year-over-year. Full-year consensus is $670.1M, rising to $802.7M next year.
Top analysts covering Bowhead Specialty Holdings Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BOW.
#1
Meyer Shields
Keefe, Bruyette & Woods · Rank #259
Buy
$36.00+4.9% to target
Overall win rate
44%
+ Follow
#2
Paul Newsome
Piper Sandler · Rank #272
Neutral
$34.00-0.9% to target
Overall win rate
50%
+ Follow
#3
Matthew J. Carletti
JMP Securities · Rank #368
Buy
$35.00+2.0% to target
Overall win rate
44%
+ Follow
#4
BH
Bob Huang
Morgan Stanley
Neutral
$34.00-0.9% to target
Coverage
—
+ Follow
#5
MS
Meyer Sheilds
Keefe, Bruyette & Woods
Buy
$36.00+4.9% to target
Coverage
—
+ Follow
BOW stock forecast FAQ
What is BOW's average 12-month price target?+
The 6 active firms with a live target average $34.67 for Bowhead Specialty Holdings Inc. over the next 12 months, ranging from a $36.00 high to a $33.00 low, as of Nov 19, 2026.
Is BOW stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 6 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 4 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for BOW?+
The Street-high target is $36.00 (Piper Sandler), and the Street-low is $33.00 (JP Morgan). The average of all 6 active-firm targets is $34.67.
How many active Wall Street firms cover BOW?+
6 active firms have a recognized rating on Bowhead Specialty Holdings Inc. as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BOW?+
Among analysts who currently cover BOW, Meyer Shields of Keefe, Bruyette & Woods has the strongest overall Quantellect track record (Rank #259). Their current call is Buy with a $36.00 target.
What is Bowhead Specialty Holdings Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.56 per share (range $0.53 – $0.59) across 5 analysts. Full-year EPS is projected at $2.03, rising to $2.46 the following year.
How much revenue is Bowhead Specialty Holdings Inc. expected to report next quarter?+
Consensus revenue is $186.0M (range $182.8M – $189.9M). Full-year revenue is projected at $670.1M, growing to $802.7M next year.
Have analysts been upgrading or downgrading BOW lately?+
As of Nov 19, 2026, 2 of 6 active firms rate BOW a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BOW calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.